Diamedix Corp.

Diamedix Corp. — FDA 510(k) Submissions

Diamedix Corp. has submitted 68 FDA 510(k) premarket notifications since 1986, of which 68 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Extractable Antinuclear Antibody, Antigen And Control, Enzyme Linked Immunoabsorbent Assay, Rubella, Reagent, Borrelia Serological Reagent, Enzyme Linked Immunoabsorbent Assay, Toxoplasma Gondii, System, Test, Rheumatoid Factor . Use the specialty filter in the sidebar to narrow results.